342 related articles for article (PubMed ID: 28661515)
1. Surfactant utilization and short-term outcomes in an era of non-invasive respiratory support in Canadian neonatal intensive care units.
Raghuram K; Mukerji A; Young J; Yee W; Seshia M; Dow K; Shah V
J Perinatol; 2017 Sep; 37(9):1017-1023. PubMed ID: 28661515
[TBL] [Abstract][Full Text] [Related]
2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
3. Use and timing of surfactant administration: impact on neonatal outcomes in extremely low gestational age infants born in Canadian Neonatal Intensive Care Units.
Stritzke A; Mohammad K; Shah PS; Ye XY; Bhandari V; Akierman A; Harrison A; Bertelle V; Lodha A
J Matern Fetal Neonatal Med; 2018 Nov; 31(21):2862-2869. PubMed ID: 28724325
[TBL] [Abstract][Full Text] [Related]
4. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
[No Abstract] [Full Text] [Related]
5. Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.
Härtel C; Herting E; Humberg A; Hanke K; Mehler K; Keller T; Mauer I; Frieauff E; Meyer S; Thome UH; Wieg C; Schmidtke S; Kribs A; Göpel W;
JAMA Netw Open; 2022 Aug; 5(8):e2225810. PubMed ID: 35943742
[TBL] [Abstract][Full Text] [Related]
6. NICU bedside caregivers sustain process improvement and decrease incidence of bronchopulmonary dysplasia in infants < 30 weeks gestation.
Mola SJ; Annibale DJ; Wagner CL; Hulsey TC; Taylor SN
Respir Care; 2015 Mar; 60(3):309-20. PubMed ID: 25425704
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
[No Abstract] [Full Text] [Related]
8. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
Xu H; Xu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.
Sankar MJ; Gupta N; Jain K; Agarwal R; Paul VK
J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S36-48. PubMed ID: 27109091
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Initial Respiratory Support Strategies in VLBW Neonates with RDS.
Afjeh SA; Sabzehei MK; Khoshnood Shariati M; Shamshiri AR; Esmaili F
Arch Iran Med; 2017 Mar; 20(3):158-164. PubMed ID: 28287810
[TBL] [Abstract][Full Text] [Related]
11. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China].
Network of Northwest Neonatal Professional Collaboration Group
Zhonghua Er Ke Za Zhi; 2015 May; 53(5):341-7. PubMed ID: 26080663
[TBL] [Abstract][Full Text] [Related]
13. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
14. Bronchopulmonary dysplasia in preterm infants managed with non-invasive ventilation or surfactant and a brief period of mechanical ventilation: a 6-year cohort study.
König K; Guy KJ
J Matern Fetal Neonatal Med; 2014 Apr; 27(6):608-11. PubMed ID: 23834679
[TBL] [Abstract][Full Text] [Related]
15. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial.
Kribs A; Roll C; Göpel W; Wieg C; Groneck P; Laux R; Teig N; Hoehn T; Böhm W; Welzing L; Vochem M; Hoppenz M; Bührer C; Mehler K; Stützer H; Franklin J; Stöhr A; Herting E; Roth B;
JAMA Pediatr; 2015 Aug; 169(8):723-30. PubMed ID: 26053341
[TBL] [Abstract][Full Text] [Related]
16. [Application of three kinds of non-invasive positive pressure ventilation as a primary mode of ventilation in premature infants with respiratory distress syndrome: a randomized controlled trial].
Gao X; Yang B; Hei M; Cui X; Wang J; Zhou G; Qu S
Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):34-40. PubMed ID: 24680406
[TBL] [Abstract][Full Text] [Related]
17. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
Rigo V; Lefebvre C; Broux I
Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
[TBL] [Abstract][Full Text] [Related]
18. Lung recruitment before surfactant administration in extremely preterm neonates with respiratory distress syndrome (IN-REC-SUR-E): a randomised, unblinded, controlled trial.
Vento G; Ventura ML; Pastorino R; van Kaam AH; Carnielli V; Cools F; Dani C; Mosca F; Polglase G; Tagliabue P; Boni L; Cota F; Tana M; Tirone C; Aurilia C; Lio A; Costa S; D'Andrea V; Lucente M; Nigro G; Giordano L; Roma V; Villani PE; Fusco FP; Fasolato V; Colnaghi MR; Matassa PG; Vendettuoli V; Poggi C; Del Vecchio A; Petrillo F; Betta P; Mattia C; Garani G; Solinas A; Gitto E; Salvo V; Gargano G; Balestri E; Sandri F; Mescoli G; Martinelli S; Ilardi L; Ciarmoli E; Di Fabio S; Maranella E; Grassia C; Ausanio G; Rossi V; Motta A; Tina LG; Maiolo K; Nobile S; Messner H; Staffler A; Ferrero F; Stasi I; Pieragostini L; Mondello I; Haass C; Consigli C; Vedovato S; Grison A; Maffei G; Presta G; Perniola R; Vitaliti M; Re MP; De Curtis M; Cardilli V; Lago P; Tormena F; Orfeo L; Gizzi C; Massenzi L; Gazzolo D; Strozzi MCM; Bottino R; Pontiggia F; Berardi A; Guidotti I; Cacace C; Meli V; Quartulli L; Scorrano A; Casati A; Grappone L; Pillow JJ
Lancet Respir Med; 2021 Feb; 9(2):159-166. PubMed ID: 32687801
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams.
Chun J; Sung SI; Ho YH; Kim J; Park GY; Yoon SA; Ahn SY; Chang YS; Park WS
J Korean Med Sci; 2017 Aug; 32(8):1288-1294. PubMed ID: 28665065
[TBL] [Abstract][Full Text] [Related]
20. Intratracheal Instillation of Budesonide-Surfactant for Prevention of Bronchopulmonary Dysplasia in Extremely Premature Infants.
Dolma K; Zayek M; Gurung A; Eyal F
Am J Perinatol; 2024 May; 41(S 01):e3065-e3073. PubMed ID: 37913780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
